Target intelligence / Profile preview

Zinc finger and other zinc-structural proteins (ZNF)

Target
ZNF
Molecular classification
Transcription factor, DNA-binding protein, RNA-binding protein, E3 ubiquitin ligase (RING finger), Protein-protein interaction module
01

Overview

Zinc finger proteins (ZNFs) represent one of the largest and most diverse superfamilies of proteins in the human genome, characterized by small structural motifs stabilized by the coordination of one or more zinc ions [NIH, 2024]. These proteins primarily function as interaction modules that bind to DNA, RNA, or other proteins, making them central regulators of gene expression, chromatin remodeling, and DNA repair [Wikipedia, 2024]. In disease contexts, dysregulation of specific ZNFs like ZEB1 and SNAIL is a hallmark of the epithelial-mesenchymal transition (EMT) in cancer, while others are critical for viral replication, such as the HIV-1 nucleocapsid protein NCp7 [NIH, 2024; Wikipedia, 2024]. Historically considered "undruggable" due to their lack of traditional active sites, ZNFs are now targeted through innovative strategies including zinc-ejecting agents that disrupt the structural fold and thalidomide-based molecular glues that induce their proteasomal degradation [ScienceDaily, 2018; NIH, 2019]. Despite their therapeutic potential, the high abundance and structural similarity among ZNF family members present significant challenges for achieving the selectivity required to avoid systemic toxicity and off-target effects [NIH, 2019; ResearchGate, 2024].

Other names
Zinc finger proteinsZNFsZinc-binding proteinsZinc-structural motifsZinc-coordinated proteins
02

Mechanism of action

Zinc ejection (displacement of Zn2+), targeted protein degradation (TPD) via E3 ligase recruitment, inhibition of DNA binding, and transcriptional modulation.

03

Biological functions

Transcription regulationChromatin remodelingDNA repairProtein degradation (Ubiquitination)RNA homeostasisCell migrationSignal transduction
04

Disease associations

CancerNeurodevelopmental disordersViral infection (e.g., HIV-1)Cardiovascular diseaseDiabetes
05

Safety considerations

Lack of selectivity leading to off-target effects on thousands of ZNFsSystemic toxicity of metal-based inhibitorsDisruption of essential DNA repair pathwaysGenomic instabilityPotential for heavy metal displacement (e.g., Pb, Cd) causing neurotoxicity
06

Interacting drugs

Thalidomide

7 more in the full profile.

07

Biomarkers

ZEB1 expression (EMT marker)SNAIL expression (EMT marker)ZNF281 expression (Cancer progression marker)Plasma zinc concentration (PZC)Serum zinc concentration (SZC)

Beyond the preview

Go deeper on Zinc finger and other zinc-structural proteins (ZNF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and other zinc-structural proteins (ZNF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call